TRANSFORMATIONS OF 5-CHLORO-2-HYDRAZINO-4-p-TOLYLSULFONYL-1,3-THIAZOLE
2135
rogen sulfide, 0.0075 mol, was added to a suspension
of 0.0015 mol of compound III in 10 ml of methanol,
and the mixture was left to stand for 20 h at 20–25°C.
The precipitate was filtered off, the solvent was
removed from the filtrate under reduced pressure, the
residue was treated with 5 ml of water and acidified
with concentrated hydrochloric acid to pH 2, and the
precipitate was filtered off and used in further
syntheses without additional purification.
EXPERIMENTAL
1
The H NMR spectra were recorded on a Varian
Mercury 400 spectrometer using DMSO-d6 as solvent
and tetramethylsilane as internal reference.
5-Chloro-2-hydrazino-4-(p-tolylsulfonyl)-1,3-thia-
zole (II). A solution of 0.5 mol of hydrazine hydrate in
10 ml of THF was added dropwise over a period of 5 min
to a solution of 0.05 mol of compound I in 10 ml of
THF, cooled to 5°C. The mixture was stirred for 5 h at
20°C, the solvent was removed under reduced
pressure, and the residue was recrystallized from
ethanol.
5-(4-Chlorophenylsulfinyl)-2-(3,5-dimethyl-1H-
pyrazol-1-yl)-4-(p-tolylsulfonyl)-1,3-thiazole (VIII).
Compound VIb, 0.01 mol, was dispersed in 5 ml of
glacial acetic acid, 0.5 ml of 30% aqueous hydrogen
peroxide was added, and the mixture was heated for
0.5 h under reflux. The solvent was removed under
reduced pressure, and the residue was recrystallized
from ethanol.
5-Chloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)-4-(p-
tolylsulfonyl)-1,3-thiazole (III). Acetylacetone,
0.09 mol, and glacial acetic acid, 0.5 ml, were added to
a suspension of 0.03 mol of compound II in 10 ml of
ethanol. The mixture was heated for 10 h under reflux
and cooled to 20°C, and the precipitate was filtered off
and recrystallized from ethanol.
5-(4-Chlorophenylsulfonyl)-2-(3,5-dimethyl-1H-
pyrazol-1-yl)-4-(p-tolylsulfonyl)-1,3-thiazole (IX). a.
Compound VIb, 0.0015 mol, was dispersed in 5 ml of
glacial acetic acid, 1 ml of 30% aqueous hydrogen
peroxide was added, and the mixture was heated for
2 h under reflux and cooled to 20°C. The precipitate
was filtered off and purified by recrystallization from
acetic acid.
2-(3,5-Dimethyl-1H-pyrazol-1-yl)-5-(p-tolyloxy)-
4-(p-tolylsulfonyl)-1,3-thiazole (IV). Compound III,
0.01 mol, was dissolved in 10 ml of THF, 0.02 mol of
p-methylphenol and 0.02 mol of triethylamine were
added, and the mixture was heated for 10 h under
reflux. The solvent was removed under reduced
pressure, and the residue was recrystallized from
ethanol.
b. Compound VIII, 0.001 mol, was dispersed in 7 ml
of glacial acetic acid, 1 ml of 30% aqueous hydrogen
peroxide was added, the mixture was heated for 2 h
under reflux and cooled to 20°C, and the precipitate
was filtered off and purified by recrystallization from
acetic acid. Samples of IX obtained as described in a
and b showed no depression of the melting point at
mixing.
2-(3,5-Dimethyl-1H-pyrazol-1-yl)-5-(pyrrolidin-
1-yl, morpholino, benzylamino)-4-(p-tolylsulfonyl)-
1,3-thiazoles Va–Vc (general procedure). Pyrrolidine,
morpholine, or benzylamine, 0.1 mol, was added to a
suspension of 0.05 mol of compound III in 10 ml of
butanol, and the mixture was heated for 20 h under
reflux. The solvent was removed under reduced
pressure, and the residue was washed with water and
recrystallized from ethanol.
2-(3,5-Dimethyl-1H-pyrazol-1-yl)-5-(methylsulfan-
yl, isopropylsulfanyl)-4-(p-tolylsulfonyl)-1,3-thiazoles
Xa and Xb (general procedure). Compound VII,
0.05 mol, was dispersed in 5 ml of methanol, 0.05 mol
of sodium methoxide and 0.065 mol of methyl iodide
or isopropyl bromide were added, the mixture was
heated for 3 h under reflux, and the precipitate was
filtered off and purified by recrystallization from
ethanol.
2-(3,5-Dimethyl-1H-pyrazol-1-yl)-4-(p-tolylsulfon-
yl)-5-(p-tolylsulfanyl, 4-chlorophenylsulfanyl)-1,3-
thiazoles VIa and VIb (general procedure). p-Methyl-
or p-chlorobenzenethiol, 0.1 mol, and triethylamine,
0.1 mol, were added to a suspension of 0.05 mol of
compound III in 10 ml of ethanol, and the mixture was
heated for 15 h under reflux. The precipitate was
filtered off, the solvent was removed from the filtrate
under reduced pressure, and the residue was
recrystallized from ethanol–DMF (10:1).
5-(4-Chlorophenylsulfonyl)-2-(3,5-dimethyl-1H-
pyrazol-1-yl)-4-(4-methoxyphenoxy)-1,3-thiazole (XI).
Compound IX, 0.05 mol, was dissolved in 10 ml of
THF, 0.1 mol of sodium 4-methoxyphenoxide was
added, and the mixture was left to stand for 24 h at 20°C.
The solvent was removed under reduced pressure, and
the residue was recrystallized from ethanol.
2-(3,5-Dimethyl-1H-pyrazol-1-yl)-4-(p-tolylsulfon-
yl)-1,3-thiazole-5-thiol (VII). Freshly prepared hyd-
RUSSIAN JOURNAL OF GENERAL CHEMISTRY Vol. 78 No. 11 2008